Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome

• Jose Ramón Vidal-Castiñeira,

  Affiliation Immunology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Antonio López-Vázquez,

  Affiliation Immunology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Jesús Martínez-Borra,

  Affiliation Immunology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Pablo Martínez-Camblor,

  Affiliation Oficina de Investigación Biosanitaria (OIB), Oviedo, Spain

  ⨯
• Jesús Prieto,

  Affiliation Liver Unit and Division of Hepatology and Gene Therapy, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain

  ⨯
• Rosario López-Rodríguez,

  Affiliation Liver Unit, Gastroenterology Service, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid and CIBERehd, Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Paloma Sanz-Cameno,

  Affiliation Liver Unit, Gastroenterology Service, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid and CIBERehd, Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Juan de la Vega,

  Affiliation Gastroenterology Service, Hospital San Agustín, Avilés, Spain

  ⨯
• Luis Rodrigo,

  Affiliation Gastroenterology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Rosa Pérez-López,

  Affiliation Gastroenterology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Ramón Pérez-Álvarez,

  Affiliation Gastroenterology Service, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Carlos López-Larrea

  * E-mail: inmuno@hca.es

  Affiliations Immunology Service, Hospital Universitario Central de Asturias, Oviedo, Spain, Fundación Renal Iñigo Álvarez de Toledo, Madrid, Spain

  ⨯